chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented to Clinic on Monday, 8/9/10 with the following symptoms that started on 7/30/10: Walking funny, weakness, ataxia, talking funny, slurry speech, garbled words, affected fine muscle skills, restless-he just could not sit still, very sensitive-he cried easily, "he was just acting funny".  Parents reported that the symptoms did come and go. Dr. was unsure what was going on and the family was sent home to monitor. Parents reported that his symptoms did improve after the visit on 8/9/10, but returned to clinic today, 8/11/10, with complaints that his symptoms are worse. Dr. suspects he has Guillain-Barre`syndrome. Dr. is sending him to Hospital for evaluation.
Feet started hurting and tingling about November 2nd. Got progressively worse throughout the week. Decided to go to doctor. Was told it was diabetic nerve pain. Went another week with feet still hurting more and more and my balance and leg strength reducing. Started getting tingling in fingers. Went to doctor again and Doctor sent me to a neurologist the following week. Kept appointment with neurologist and neurologist told me it was diabetic nerve pain. Numbness in feet and hands, pain in feet, and balance getting worse. Getting difficult to put on socks and shoes and open jars with hands. Got a cane because people thought I was drunk when I entered a room. Unable to carry a cup of coffee.  Went to a podiatrist to have feet checked out. Podiatrist called General Practitioner to say that they needed to take a look at me as something was going on. GP's office called and set me up to come in the following week. In the meantime I was talking with someone and he said that his relative had the same problem. CIDP. When I looked it up it sounded just like what I had. I brought this info to my GP and GP agreed that it very well could be GBS and wrote a note to the neurologist with whom I had an appointment that same day. Neurologist also agreed with this and told me to go to the emergency room right away and I would be tested and admitted for treatment.  This was in early December 2015.  Did a Nerve conduction test and a Spinal Tap. Spinal Tap found protein for GBS.  I received 5 days if IVIG in hospital and then sent to rehab for 2 weeks. I did walk into rehab very erratically with cane. Last time I walked by myself from that point to January 30th.  Unable to identify objects in my hands without looking. On January 1, 2016 I went to emergency and was admitted and treated with 5 courses of plasmapheresis over a 5 day span.  I was then discharged from the hospital and insisted on going home instead of rehab.  I did not feel that rehab had done anything for me the previous time I was there.  I was home for two weeks and I started to feel worse again.  Went to hospital again and was admitted again and again treated with 5 courses of plasmapheresis over a 5 day span.  Upon completion of the plasmapheresis, I was placed on 60 mg of prednisone per day.  I was taken home in a wheelchair and after a couple of days, I went to a walker.  After a couple more days, I felt stronger and started experimenting with releasing the walker and taking steps on my own.  On the 4th day after release from the hospital, I was walking on my own.  I did very well for the next 8 months and then on October 29, 2016, I started feeling pains in my feet again and progressed to tingling and starting to lose my balance for no reason.  Because of a hurricane on the east coast, I was unable to contact my doctor until October 10, 2016.  The doctor placed me on prednisone and that is where I'm at right now.  If I don't progress toward the recovery side in 3 or 4 days, I'll head for the emergency room.
Tested Positive for Hepatitis B; Initial Report Received on 16-Dec-2022  A pharmacist reported that a patient (age, gender, race, and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and the patient tested positive for hepatitis-B.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On an unspecified date, the patient received a dose of HEPLISAV-B (Lot #, expiration date, NDC # 43528-002-01, and route not reported) in an unspecified route and site from a pharmacist.   On an unspecified date, 1.5 days after having been vaccinated with HEPLISAV-B, the patient tested positive for hepatitis-B.  The reported indicated that he did not have any additional details regarding the case.    Company Comment: The company assessed the event as non-serious.  Immunological vaccine failure not confirmed due to lack of information on serological titer and doses of vaccine administered.; Sender's Comments: The company assessed the event as non-serious.  Immunological vaccine failure not confirmed due to lack of information on serological titer and doses of vaccine administered.
This case was reported by a consumer via call center representative and described the occurrence of chronic arthritis in a 26-year-old female patient who received ENGERIX B adult (batch number SKBENGB212A6, expiry date unknown). Co-suspect products included LYMERIX (batch number LYM194B9, expiry date unknown). Previously administered products included LYMERIX (1st dose received in 1999), LYMERIX (2nd dose received in 16th November 1999, batch number LY120F9), ENGERIX B adult (1st dose received on an unknown date, batch number ENG3001A4), ENGERIX B adult (2nd dose received on 16th November 1999, batch number SKBENG3074A), Influenza (received in October 1999, batch number U0067AA) and HAVRIX adult (2nd dose received in October 1999, batch number VHA584A4). On 3rd May 2000, the patient received the 3rd dose of ENGERIX B and the 3rd dose of LYMERIX. On an unknown date, an unknown time after receiving ENGERIX B adult and LYMERIX, the patient experienced chronic arthritis. On an unknown date, the outcome of the chronic arthritis was unchanged. It was unknown if the reporter considered the chronic arthritis to be related to ENGERIX B and LYMERIX.
few hrs p/vax devel elevated temp; mom gave APAP as directed; temp went to 104.9; call family MD who advised cont APAP; some vomiting; generalized rash;
p/vax pt lt arm @ inj site very sore; 8/19 remained sore; swollen & red over entire upper arm inner & outer aspect; 8/30 came to hosp  & was observed small bruise @ site of inj; redness noted on upper arm & inner aspect opposite site of inj
Patient had several ED visits after receiving COVID vaccination; on 4/25/2021, 4/28/2021, 5/8/2021. On 5/12/2021 patient received second vaccination. More ED visits on 5/22/2021, 5/29/2021, 5/31/2021. On 6/3/2021 patient presented to the ED with shortness of breath and was subsequently hospitalized.
Patient presented to the pharmacy 3 days after immunization with left arm red and swollen. Patient stated that the swelling and pain has subsided some since previous day.
Information has been received from a physician concerning a 13 year old male who on 09-MAY-2012 was vaccinated intramuscularly with the first, 0.5ml dose of GARDASIL (Lot# 672721/0101AE, expired in October 2014). Secondary suspect therapy on the same day included the second dose of VARIVAX, SC (Lot# 671861/1907AA). On 09-MAY-2012 during the office visit the patient developed syncope and seizure like movements after receiving his injection of GARDASIL. The patient was advised to lie down and elevate the legs as treatment. On 09-MAY-2012 the patient recovered. The patient's mother did not want him to receive the rest of the series, the action taken was unknown at this time. Upon internal review, seizure like movements was determined to be an other important medical event. Additional information has been requested.
This spontaneous report was received from a 65-year-old male consumer with no pertinent medical history, concurrent conditions, concomitant therapies, and drug reactions or allergies. Historical vaccine include: Approximately on 01-FEB-2017 reported as "six weeks prior", the patient received a dose of PNEUMOVAX 23 for prophylaxis (dose, route, lot number, expiration date, and frequency were unspecified); and subsequently, on 13-MAR-2017, the patient was vaccinated with a dose of ZOSTAVAX on his left arm, therapy route reported as "vaccine", dose and frequency reported as "one-time vaccine" (strength, lot number, and expiration date were not provided) for prophylaxis (reported as shingles). Afterward, on 15-MAR-2017, the patient had a reaction at the injection site and additionally, the patient reported that he experienced irritation and swelling "around the size of a golf ball", in the injection site. The patient sought unspecified medical attention but no laboratory tests or diagnostic procedures were performed, however, it was reported that the patient received an unspecific treatment. At the time of this report, it was unknown whether the patient recovered or not from the adverse events. The causal relationship between the therapy with ZOSTAVAX and the adverse events were not provided. No product quality complaint was involved. Additional information has been requested.
Minutes after vaccine, Felt nauseous and shortly fainted afterwards. Regained consciousness after a couple minutes.
second dose of shingrix is later than 6 months; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of Shingrix on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were reported as follows: Age at vaccination was not reported. The patient received a dose of Shingrix and the second dose was received later than 6 months which led to lengthening of vaccination schedule. Consent to follow up was not possible as no contact details were available.
Day of vaccine I had a burning sensation at injection site. As day went on the burning sensation was felt through out my nervous system. It seemed every nerve and joint thru out my body was on fire. Every movement and touch burned. The pain became worse as evening hit. I also had nausea and headache. Day 2 the burning sensation had subsided but I now had muscle pain all over my body. I managed headache with exedrin but suffered through pain as I don't like to take to many meds at one time. Was still nauseas on day two.  Ran a fever over night but broke by day 3. Today is day 3 and still suffering and fighting through headache and now fatigue. But that is to be expected with the amount of pain for past 2 days. Starting to get appetite back. Noticed some sneezing and some chest pain today but holding and doesn't seem to be getting worse. I treated my symptoms accordingly with over the counter meds. Try to drink plenty of water as I felt dehydrated form the ordeal. I read on the possible side effects and my experience seemed quite diffterent. So i thought I would report it.
1.  Hives:  Noticed 12-20 hours after vaccination (early next morning).  Developed itchy, red welts on neck, abdomen, upper legs, back.  Lasted for 7 days.   2.  Light-headed, dizziness, loss of balance:  Within 3-5 hours of vaccination.  Lasted 3 days.   3.  Facial swelling:  Noticed 12-20 hours after vaccination (next morning on waking).  Lasted 5-7 days. 4.  Fatigue: Started within 3-5 hours and lasted 3-5 days. 5. Headache:  Within 3-5 hours; Lasted 3 days;  Ibuprofen started 24 hours after vaccination and taken for 3 days 6.  Injection site pain: Within 1-2 hours and worsened over 24 hours. Lasted 7 days;  Ibuprofen started 24 hours after vaccination and taken for 3 days.
arm became swollen; This case was reported by a consumer via interactive digital media and described the occurrence of swelling arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was recovered/resolved.   It was unknown if the reporter considered the swelling arm to be related to Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient received a dose of Shingles and experienced arm swelling which stayed that way for over two years. The patient hoped that he/she would never get shingles but was not sure how safe the vaccine really was. The consent to follow up was not possible as no contact details were available. This case was linked to US2021AMR183057; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183057:Response to post
Client received second dose of COVID vaccine. Post vaccine proceeded straight to bathroom and stated that he then vomited in bathroom. Client stated he was not feeling well prior to arrival to vaccine pod. Patient placed in observation room  with EMS, symptoms persisted. vs's revealed that client was hypotensive and bradycardic, client transferred to hospital via ambulance.
arm soreness; This is a spontaneous report from a contactable Other HCP (Patient) via Medical information team. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown) via an unspecified route of administration on Jan2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient previously took 1 mg of Prednisone up until 6 months ago because she had an anaphylaxis reaction to a vitamin drip. On unspecified date in Jan2021 (about 2 days after vaccination), the patient doesn't have any side effects except arm soreness. She got nervous the morning before getting her vaccine of a reaction and took a very small amount of prednisone before getting the vaccine. Her second dose was scheduled for 25 days. The seriousness of the event was reported as non-serious. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
From 11-2:30 I have severe chills, about 3pm the chills kind of subsided but I developed a massive headache.  It eased up about 6pm and went to sleep.  The next few days I felt groggy.  The injection site got really hard for about 5 days and subsided
Chills and body aches; Tylenol taken to mildly relieve symptoms; sleep and hydration
itchy hives at the injection site; severe pain at the injection site; episodes of chills; felt feverish; her highest measured; nausea; muscle and joint pain; muscle and joint pain; fatigue; injection site swelling; limits the mobility of that [right] arm; migraine headache; 3" x 3" patch of itchy, painful hives on her right thigh; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (limits the mobility of that [right] arm), MIGRAINE (migraine headache), URTICARIA (3" x 3" patch of itchy, painful hives on her right thigh), VACCINATION SITE URTICARIA (itchy hives at the injection site) and VACCINATION SITE PAIN (severe pain at the injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2019, the patient experienced MIGRAINE (migraine headache) and URTICARIA (3" x 3" patch of itchy, painful hives on her right thigh). On 14-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (limits the mobility of that [right] arm), VACCINATION SITE URTICARIA (itchy hives at the injection site), VACCINATION SITE PAIN (severe pain at the injection site), CHILLS (episodes of chills), PYREXIA (felt feverish; her highest measured), NAUSEA (nausea), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain), FATIGUE (fatigue) and VACCINATION SITE SWELLING (injection site swelling). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (limits the mobility of that [right] arm), MIGRAINE (migraine headache), URTICARIA (3" x 3" patch of itchy, painful hives on her right thigh), VACCINATION SITE URTICARIA (itchy hives at the injection site), VACCINATION SITE PAIN (severe pain at the injection site), CHILLS (episodes of chills), PYREXIA (felt feverish; her highest measured), NAUSEA (nausea), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain), FATIGUE (fatigue) and VACCINATION SITE SWELLING (injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
It was a short pain it made my arm week; Start pain like I am having heart attack and I can''t stop maybe it''s just like a chest pain like some bad spicy food like something pretty serious/I felt the first severe chest pain.; It was a short pain it made my arm week.; I was scared; This is a spontaneous report from a contactable consumer (patient himself). A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3183, Expiry Date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 25Sep2021 as dose 1, single for COVID-19 immunization (Age at Vaccination was 45 years). The patient medical history included nephrolithiasis (He have kidney stone sometimes his kidney stone but kidney stone but not have now, He had over the years or approx.,15 years, no, currently he has no medical condition. It was reported that, patient was healthy before vaccination and did not take any other products before vaccination. The patient's concomitant medications were not reported. On 25Sep2021, the patient experienced start pain like he had a heart attack, and he cannot stop. Maybe it is just like a chest pain like some bad spicy food like something pretty serious/He felt the first severe chest pain (he still having the chest pain and the chest pain continues and does not stop in a while, it was like if he asks his doctor and sit out for like a trying lay down), it was a short pain it made his arm weak, he was scared. Patient visited emergency room as a result of events. The patient underwent lab tests and procedures which included blood urea: normal (kidney function was normal), X-RAY of ribs: normal (does not had crack and my vitals were normal), vitals: normal and EKG: normal on an unspecified date. Therapeutic measures were taken as a result of start pain like he had a heart attack, and he cannot stop. Maybe it is just like a chest pain like some bad spicy food like something pretty serious/He felt the first severe chest pain include Tylenol. The outcome of the events was unknown.    Follow-up attempts are completed. No further information is expected.
Flushing accompanied by redness started about 25 minutes after shot while driving home. Chest heaviness without SOB or difficulty swallowing. Itching began starting with face then neck, chest and torso. Itching then spread to the whole body with a patina rash appearing on the face, neck and chest a few hours later. Immediately took dose of liquid Benedryl upon arriving home. Followed up by dose of Zyrtec. Continued monitoring sxs throughout the evening. Took additional 2 doses of Benedryl with a dose of Singular.  Sxs severity lessoned though the night and into the next day. Mild itching and a few patches of the rash remained the next day 1/20/21. Continued taking antihistamine and allergy medication. All sxs have resolved as of 1/21/21
Woke up with hives on torso, 12/11/09 some breathing discomfort after visiting a perfume store; no treatment, no visit to PMD and parent sent to school as normal 12/14/09.
After Covid vaccination #1, patient was instructed to be monitored for 30 minutes due to history of sulfa allergy.  After about 5 minutes of observation, she approached me (pharmacist) saying she had tingling and a little numbness in right side of lower face.  She reported no difficulty breathing and no other symptoms.  I consulted the two other pharmacists I was with and we decided to not take any immediate action but continue monitoring.  I checked in with patient every few minutes to ask if symptoms were getting better/worse.  For first 30 minutes, pt said symptoms were the same.  After about 30 minutes, she said she had a little itching down her throat, but still no difficulty breathing.  We gave her 50 mg diphenhydramine and monitored for 30 more minutes.  After 1 full hour of observation, she never reported difficulty breathing.  She did get tired from the Benadryl and was up on moving around and said feeling slightly better.  After 1 hour, she went back to her room.
A report has been received from a Pharmacist concerning a 9 month old, female subject who had been receiving Nasal FLUMIST (intranasal), 0.2 ml ONCE for INFLUENZA VACCINATION. FLUMIST (intranasal) started on 05-Nov-2015 for INFLUENZA VACCINATION. The patient experienced INADVERTENTLY ADMINISTERED TO A PATIENT 10 MONTHS OLD. FLUMIST (intranasal) was discontinued on 05-Nov-2015. The outcome of the event of INADVERTENTLY ADMINISTERED TO A PATIENT 10 MONTHS OLD is unknown. The reporter's description of the event (s) was as follows: None. The report was considered to be non-serious. The reporter and company physician considered that there was no causal relationship between INADVERTENTLY ADMINISTERED TO A PATIENT 10 MONTHS OLD and FLUMIST.
I had the first dose of Moderna on Friday, May 7. A week later (May 14), I developed a red itchy rash on my upper right arm, on the site of the injection. It went away by May 21.
Localized redness, swelling of thigh to double in size, warm to touch and itching.
Slight exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Slight exhaustion) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Slight exhaustion). At the time of the report, FATIGUE (Slight exhaustion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
The evening after receiving FLUZONE, patient developed a 1 inch area around the injection site which was itchy. Patient was given TYLENOL and hydro cortisone cream at home. Patient then developed swelling in left thigh from injection site down to knee. No fever or rash noted currently.
Same day post vax, the pt developed apnea type spells two times and limpness. She was admitted to the hospital.